These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8505852)

  • 1. Induction of surface antigen recognized by new monoclonal antibody, YU311, on 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line.
    Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Uchiyama M; Shibata A
    Leuk Res; 1993 Jun; 17(6):541-5. PubMed ID: 8505852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2).
    Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A; Tsuruo T
    Leuk Res; 1994 Sep; 18(9):709-15. PubMed ID: 7934146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of the deoxycytidine kinase (dCK) gene in a 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line KY-Ra.
    Kobayashi T; Kakihara T; Uchiyama M; Fukuda T; Kishi K; Shibata A
    Leuk Lymphoma; 1994 Nov; 15(5-6):503-5. PubMed ID: 7874009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines.
    Kees UR; Ford J; Dawson VM; Piall E; Aherne GW
    Cancer Res; 1989 Jun; 49(11):3015-9. PubMed ID: 2720661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S; Turner A; Nelms P; Yanovich S
    Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug-resistant sublines.
    Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A
    Leuk Res; 1993 Apr; 17(4):325-32. PubMed ID: 8387619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
    Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity to 1-beta-D-arabinofuranosylcytosine in P388 murine leukemic cells resistant to etoposide.
    Higashigawa M; Ido M; Ohkubo T; Kawasaki H; Kamiya H; Sakurai M; Taniguchi K; Hamazaki M
    Leuk Res; 1989; 13(1):39-42. PubMed ID: 2915574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M; Ido M; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M; Taniguchi K; Hamazaki M
    Leuk Res; 1991; 15(4):255-62. PubMed ID: 2030607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses.
    Negoro E; Yamauchi T; Urasaki Y; Nishi R; Hori H; Ueda T
    Int J Oncol; 2011 Apr; 38(4):911-9. PubMed ID: 21290089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine-resistant human leukemia cell line: new monoclonal antibodies to a 65kDa membrane protein.
    Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Shibata A
    Leuk Lymphoma; 1992 May; 7(1-2):157-64. PubMed ID: 1472928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
    Horber DH; Schott H; Schwendener RA
    Br J Cancer; 1995 May; 71(5):957-62. PubMed ID: 7734320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human granulocyte colony-stimulating factor enhanced cytotoxicity of Ara-C in Ara-C-resistant leukemic cells from a patient with biphenotypic leukemia in cell kinetic quiescence.
    Higashigawa M; Komada Y; Washio N; Kuwabara H; Hori H; Ido M; Sakurai M
    Leuk Res; 1992 Oct; 16(10):1049-54. PubMed ID: 1383642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
    Yamamoto S; Yamauchi T; Kawai Y; Takemura H; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Int J Hematol; 2007 Feb; 85(2):108-15. PubMed ID: 17321987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.